| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/30/2008 | US20080269141 Peptide Substance Restoring Myocardium Function |
| 10/30/2008 | US20080269129 Polypeptide and dna thereof useful as a neovascular marker |
| 10/30/2008 | US20080269128 Albumin Fusion Proteins |
| 10/30/2008 | US20080269127 Albumin Fusion Proteins |
| 10/30/2008 | US20080269126 Albumin Fusion Proteins |
| 10/30/2008 | US20080269125 Albumin Fusion Proteins |
| 10/30/2008 | US20080269109 System and method of resuscitation of a mammal |
| 10/30/2008 | US20080268536 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor |
| 10/30/2008 | US20080268489 Therapeutic polypeptide for use in treatment of heart, hypothermic and cardiovascular disorders |
| 10/30/2008 | US20080268076 retrofractamide A, pipercide, piperrolein B, piperchabamide D, pellitorin or combinations thereof; preventing and treating vascular diseases, such as hyperlipidemia, arteriosclerosis, etc. |
| 10/30/2008 | US20080268049 having reduced levels of 3-ethyl methyl [(2-aminoethoxy)methyl](2-chlorophenyl)methylpyridine-3,5 dicarboxylate ("impurity D") and total impurities when free of dicalcium phosphate |
| 10/30/2008 | US20080268044 Novel Process and Formulations |
| 10/30/2008 | US20080268033 Biologically active methylene blue derivatives |
| 10/30/2008 | US20080268030 Gene therapy for diabetic ischemic disease |
| 10/30/2008 | US20080268018 Method for forming crystallized therapeutic agents on a medical device |
| 10/30/2008 | US20080268014 Ethanamine, 2-L[5-oxido-4-phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy]-N,N-bis[2-[[5-oxido-4-(phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy]ethyl]-; cardiovascular diseases; inhibiting platelet aggregation, platelet adhesion caused by the exposure of blood to a medical device; abnormal cell proliferation |
| 10/30/2008 | US20080267962 Albumin Fusion Proteins |
| 10/30/2008 | US20080267939 Plant extract for use in treatment and prevention of hypertensive disorders |
| 10/30/2008 | US20080267938 Cardiac phyto-nutraceutical synergistic composition |
| 10/30/2008 | US20080267927 Using electrical pulses and embryonic stem cell culture to enhance propagation of cardiac tissue; tissue engineering and repair; regenerative medicine |
| 10/30/2008 | US20080267921 Cardiac Stem Cells |
| 10/30/2008 | US20080267912 Novel inhibitors of glutaminyl cyclase |
| 10/30/2008 | US20080267909 Using acetyl-low density lipoprotein (acetyl-LDL) and an acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor as stimulatory tools in identifying modulators which treat and/prevent heart, cardiovascular and diabetic disorders |
| 10/30/2008 | US20080267887 Such as 5-(2,6-diethyl-phenyl)-1H-pyrrolo[2,3-C]pyridine, which binds C5a receptors with high affinity; for treatment of inflammatory, cardiovascular, and immune system disorders; kits |
| 10/30/2008 | US20080267877 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 10/30/2008 | US20080267871 Cardioinhibitory/ Antihypertensive Novel Endogenous Physiologically Active Peptide |
| 10/30/2008 | DE102007019691A1 Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie Use of substituted acyclic Furopyrimidin derivatives for the treatment of pulmonary arterial hypertension |
| 10/30/2008 | DE102007019690A1 Verwendung von cyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie Using cyclic substituents Furopyrimidin derivatives for the treatment of pulmonary arterial hypertension |
| 10/30/2008 | CA2721739A1 Drug combination and its use in the treatment of muscle loss |
| 10/30/2008 | CA2684644A1 Quinoline-carboxamide derivatives as p2y12 antagonists |
| 10/30/2008 | CA2684356A1 Oxazolidinones for the treatment and prophylaxis of pulmonary hypertension |
| 10/30/2008 | CA2684003A1 Novel compounds as cannabinoid receptor ligands |
| 10/30/2008 | CA2683534A1 Novel pyrimidine compound having dibenzylamine structure and medicament comprising the same |
| 10/30/2008 | CA2680039A1 Pharmaceutical composition comprising edoxaban, an anticoagulant |
| 10/29/2008 | EP1985632A2 Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation |
| 10/29/2008 | EP1985308A2 Water-soluble compositions of bioactive lipophilic compounds |
| 10/29/2008 | EP1985307A2 Method and preparation for preventing and/or treating depression |
| 10/29/2008 | EP1985297A1 Carboxylic acid compound and use thereof |
| 10/29/2008 | EP1985296A1 New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease |
| 10/29/2008 | EP1984345A1 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
| 10/29/2008 | EP1984040A1 Drug-eluting intravascular prostheses and methods of use |
| 10/29/2008 | EP1984026A2 Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients |
| 10/29/2008 | EP1984012A2 Use of peptidic vasopressin receptor agonists |
| 10/29/2008 | EP1984010A2 Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
| 10/29/2008 | EP1984002A1 Trialkylsilylbenzylaminocarboxyindoles, indazoles and indolines and their use in treating cetp-mediated disorders |
| 10/29/2008 | EP1983990A1 A3 adenosine receptor allosteric modulators |
| 10/29/2008 | EP1983985A1 Use of naphthyridine derivatives as medicaments |
| 10/29/2008 | EP1983833A2 Method for promoting myocardial regeneration and uses thereof |
| 10/29/2008 | EP1853280A4 Compositions and methods for treating and preventing cardiomyopathy and heart disease |
| 10/29/2008 | EP1668001B1 Substituted heteroaryl benzofuran acids |
| 10/29/2008 | EP1589986B1 Methods and uses of the integrin alpha 10 chain, for diagnosing and detecting atherosclerosis plaque formation in vitro |
| 10/29/2008 | EP1505959B1 Use of edg receptor binding agents in cancer |
| 10/29/2008 | EP1406698B1 Lipoxin analogs as novel inhibitors of angiogenesis |
| 10/29/2008 | EP1406650B1 Use of poly-glu, tyr for neuroprotection therapy of the cns or pns |
| 10/29/2008 | EP1313574B1 Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same |
| 10/29/2008 | EP1295936B1 Method of preparing heart muscle cells and method of searching for remedy for heart diseases |
| 10/29/2008 | EP1263739B9 Crystalline salts of 7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino pyrimidin-5-yl -(3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 10/29/2008 | EP1216228B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 10/29/2008 | EP1144592B1 Substrate for cell growth |
| 10/29/2008 | CN101296926A Heterocyclic aspartyl protease inhibitors |
| 10/29/2008 | CN101296731A Novel benzopyran derivatives as potassium channel openers |
| 10/29/2008 | CN101296692A Rh-epo nasal formulations with low sialic acid concentration for the treatment of diseases of the central nervous system |
| 10/29/2008 | CN101293869A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561lck tyrosine kinases |
| 10/29/2008 | CN101293831A Uses of 3-hydroxy fatty acid and its derivative in preparing calcium ion duct modifying agent |
| 10/29/2008 | CN101293082A Anti-heart failure pharmaceutical composition for improving skeletal muscle function and preparation method thereof |
| 10/29/2008 | CN101293067A Capsule for coronary disease |
| 10/29/2008 | CN101293058A Medicament for treating hypertension |
| 10/29/2008 | CN101293055A Scutellaria health tea and its processing method |
| 10/29/2008 | CN101293026A Process for preparing Chinese medicinal herb for treating hemorrhoid |
| 10/29/2008 | CN101293010A Myocarditis rehabilitation pill and preparation method thereof |
| 10/29/2008 | CN101293003A Effect section of frangrant ainsliaea herb, preparation method and application thereof |
| 10/29/2008 | CN101292984A Hydroxide benzenesulfonic acid alkyl pyrazine medicaments, preparation method and application thereof |
| 10/29/2008 | CN101292973A Use of chicoric acid in preparing medicaments for treating coronary disease |
| 10/29/2008 | CN101292970A Use of 3,4-dihydroxy coffee acyl group tartaric acid in preparing medicaments for coronary disease |
| 10/29/2008 | CN101292962A Felodipine controlled release formulation and preparation method thereof |
| 10/29/2008 | CN101292959A Daidzein powder injection and preparation method thereof |
| 10/29/2008 | CN101292733A Scentless healthy garlic powder (piece) nonhygroscopic agglomeration oxidation disintegration resistant preparation method |
| 10/29/2008 | CN101292685A Health care edible oil |
| 10/29/2008 | CN100429232C Vaughan Tristan J. |
| 10/29/2008 | CN100429219C Celosia argentea suponin compound and its pharmaceutical use |
| 10/29/2008 | CN100429210C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
| 10/29/2008 | CN100429201C Heterocyclic compounds and methods of use thereof |
| 10/29/2008 | CN100429196C Extraction process and application of emodin and aloe-emodin |
| 10/29/2008 | CN100428959C Process for producing drug ultramicroparticle and apparatus therefor |
| 10/29/2008 | CN100428940C Notoginsenoside pharmaceutical composition and method for preparing the same and use thereof |
| 10/29/2008 | CN100428937C Levosimendan freeze-drying composition |
| 10/28/2008 | USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent |
| 10/28/2008 | US7442837 Phenethanolamine derivatives for treatment of respiratory diseases |
| 10/28/2008 | US7442836 Phenethanolamine derivatives for treatment of respiratory diseases |
| 10/28/2008 | US7442807 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 10/28/2008 | US7442805 Substituted sulfonamide-indoles |
| 10/28/2008 | US7442792 halogenation of pyrazolo[1,5-a][1,3,5]triazin-4-ol's, with phosphorus oxyhalides, then dehalogenation and amination to yield dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine's, used as corticotropin releasing factor (CRF) receptor antagonists; anxiolytic agents; antidepressants |
| 10/28/2008 | US7442791 Aminoalkylamide substituted cyclohexyl derivatives |
| 10/28/2008 | US7442790 Caspase inhibitors and uses thereof |
| 10/28/2008 | US7442763 Kidney diseases |
| 10/28/2008 | US7442719 Methods using phenethanolamine derivatives for treatment of respiratory diseases |
| 10/28/2008 | US7442717 Compounds for treatment of sleep apnea, respiratory system disorders or kidney failure |
| 10/28/2008 | US7442713 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 10/28/2008 | US7442712 Constrained himbacine analogs as thrombin receptor antagonists |
| 10/28/2008 | US7442708 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia |